These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25832442)

  • 21. Mixed models for longitudinal left-censored repeated measures.
    Thiébaut R; Jacqmin-Gadda H
    Comput Methods Programs Biomed; 2004 Jun; 74(3):255-60. PubMed ID: 15135576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Piecewise Growth Mixture Tobit Models: Application to AIDS Studies.
    Dagne GA
    J Biopharm Stat; 2015; 25(6):1339-52. PubMed ID: 25629898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mixed-effects location and scale Tobit joint models for heterogeneous longitudinal data with skewness, detection limits, and measurement errors.
    Lu T
    Stat Methods Med Res; 2018 Dec; 27(12):3525-3543. PubMed ID: 28414259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two-sample tests of area-under-the-curve in the presence of missing data.
    Spritzler J; DeGruttola VG; Pei L
    Int J Biostat; 2008 Jan; 4(1):Article 1. PubMed ID: 20231907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A mixture of hierarchical joint models for longitudinal data with heterogeneity, non-normality, missingness, and covariate measurement error.
    Huang Y; Yan C; Yin P; Lu M
    J Biopharm Stat; 2016; 26(2):299-322. PubMed ID: 25629642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous inference for longitudinal data with detection limits and covariates measured with errors, with application to AIDS studies.
    Wu L
    Stat Med; 2004 Jun; 23(11):1715-31. PubMed ID: 15160404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous inference and bias analysis for longitudinal data with covariate measurement error and missing responses.
    Yi GY; Liu W; Wu L
    Biometrics; 2011 Mar; 67(1):67-75. PubMed ID: 20528858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of antiretroviral immunotherapy trials with potentially non-normal and incomplete longitudinal data.
    Mogg R; Mehrotra DV
    Stat Med; 2007 Feb; 26(3):484-97. PubMed ID: 16625520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A structured framework for assessing sensitivity to missing data assumptions in longitudinal clinical trials.
    Mallinckrodt CH; Lin Q; Molenberghs M
    Pharm Stat; 2013; 12(1):1-6. PubMed ID: 23193075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What can go wrong when ignoring correlation bounds in the use of generalized estimating equations.
    Sabo RT; Chaganty NR
    Stat Med; 2010 Oct; 29(24):2501-7. PubMed ID: 20690109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of multi-outcome longitudinal studies.
    Jensen SM; Pipper CB; Ritz C
    Stat Med; 2015 May; 34(12):1993-2003. PubMed ID: 25720498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of statistical methods for analysis of clustered binary observations.
    Heo M; Leon AC
    Stat Med; 2005 Mar; 24(6):911-23. PubMed ID: 15558576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimation and inference on correlations between biomarkers with repeated measures and left-censoring due to minimum detection levels.
    Xie X; Xue X; Gange SJ; Strickler HD; Kim MY;
    Stat Med; 2012 Sep; 31(21):2275-89. PubMed ID: 22714546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Joint modeling of longitudinal data and informative dropout time in the presence of multiple changepoints.
    Ghosh P; Ghosh K; Tiwari RC
    Stat Med; 2011 Mar; 30(6):611-26. PubMed ID: 21337357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment effects in randomized longitudinal trials with different types of nonignorable dropout.
    Yang M; Maxwell SE
    Psychol Methods; 2014 Jun; 19(2):188-210. PubMed ID: 24079928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modeling observations with a detection limit using a truncated normal distribution with censoring.
    Williams JR; Kim HW; Crespi CM
    BMC Med Res Methodol; 2020 Jun; 20(1):170. PubMed ID: 32600261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blinded assessment of treatment effects utilizing information about the randomization block length.
    Miller F; Friede T; Kieser M
    Stat Med; 2009 May; 28(12):1690-706. PubMed ID: 19340815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simple adjustments for randomized trials with nonrandomly missing or censored outcomes arising from informative covariates.
    Baker SG; Fitzmaurice GM; Freedman LS; Kramer BS
    Biostatistics; 2006 Jan; 7(1):29-40. PubMed ID: 15923407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interval-censored parametric regression survival models and the analysis of longitudinal trials.
    Mackenzie G; Peng D
    Stat Med; 2013 Jul; 32(16):2804-22. PubMed ID: 23297174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maximum likelihood estimation in survival studies under progressive interval censoring with random removals.
    Xiang L; Tse SK
    J Biopharm Stat; 2005; 15(6):981-91. PubMed ID: 16279356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.